WU Wei-qiang, et al. Expression of EGFR ,WT-1,CD10 and OTR in endometrial stromal sarcomas. [J]. Journal of Chongqing Medical University 34(7):837-840(2009)
WU Wei-qiang, et al. Expression of EGFR ,WT-1,CD10 and OTR in endometrial stromal sarcomas. [J]. Journal of Chongqing Medical University 34(7):837-840(2009)DOI:
Expression of EGFR ,WT-1,CD10 and OTR in endometrial stromal sarcomas
Objective:To explore the expression of Epidermal growth factor recepto(rEGFR)
WT-1
CD10 and Oxytocin receptors(OTR)in endometrial stromal sarcomas
and their applications in the diagnosis and differential diagnosis of Endometrial stromal sarcoma(ESS). Methods: Using the routine SP immunohistochemical technique
the expression of epidermal growth factor receptor(EFGR)
the Wilms’ tumor gene(WT-1)
CD10 and oxytocin receptors(OTR)was studied in 40 cases of endometrial stromal sarcoma (ESS)
including 35 low-grade cases and 5 cases of undifferentiated endometrial sarcoma(UES)
15 cases of highly cellular leiomyoma(HCL)and 10 cases of leiomyosarcoma(LMS). Results: Immunoreactives of ESS for EGFR
WT-1
CD10 and OTR were 67.5%(27/40)
52.5%(21/40)
82.5% (33/40)and 7.25%(3/40)respectively;whereas in the first control group
the positive rates of HCL were 80.0%(12/15)
46.7%(7/15)
13.3%(2/15)and 100%(15/15);and
in the second control one
the positive rates of LMS were 70.0%(7/10)
50.0%(5/10)
0(0/10)and 100%(10/10)
respectively (P<0.05). Among ESSs
27 of 40 were positive for expression of EGFR
as were 7 LMSs and 12 HCLs.WT-1 was expressed in 21 cases of low grade ESSs
5 of 10 LMSs and 7 of 15 cases of HCLs
but that expression was lost in 5 cases of UESs. 7 cases of ESSs showed no expression about CD10
including 4 cases of UESs.Only 2 cases of HCLs were positive for CD10. The tumor cells of 33 low-grade ESSs and 4 UESs were negative for OTR except in regions of smooth muscle differentiation
which was present in 3 cases. All 15 HCLs showed cytoplasmic expression of OTR in 100% of the tumor cells with strong intensity. All 10 LMSs expressed OTR withmoderate to strong intensity in 100% of the tumor cells in 8 cases and weak staining in 5%~25% of tumor cells in the remaining 2 cases. Conclusion:The expression of EGFR and WT-1 can befound in the endometrial stromal sarcomas
highly cellular leiomyomas and leiomyosarcomas. To be a specific immunohistochemical marker of ESS
the expression of CD10 is more specific than that of EGFR or WT-1. CD10 and OTR can aid in the distinction of uterine smooth muscle tumors from ESSs.